兩連板美諾華(603538.SH):尚無阿比多爾原料藥及製劑商業化生產
格隆匯2月6日丨美諾華(603538.SH)公佈,公司股票於連續2個交易日漲停。
宣城美諾華與先聲製藥合作研發事項僅有意向性約定,尚未簽訂正式的合作協議,後續合作的開展仍存在一定的不確定性;合作協議所涉研發產品尚處於小試階段,後續還需經小試、中試、申報註冊成功後方能實現商業化生產,研發週期及研發能否取得成功存在不確定性;由於藥品研發週期較長,受市場等客觀因素影響,存在銷售不及預期的風險。
目前,公司尚無阿比多爾原料藥及製劑的商業化生產,請廣大投資者注投資風險,理性決策,審慎投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.